<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Evaluating the efficacy of mixture of Boswellia carterii, Zingiber officinale, and Achillea millefolium on severity of symptoms, anxiety, and depression in irritable bowel syndrome patients</title><FirstPage>10726</FirstPage><LastPage>10726</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorders (FGIDs) that a?ects in&lt;/span&gt;&lt;table class="NormalTable"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="550"&gt;&lt;span class="fontstyle2"&gt;di?erent aspects of life and patients experienced depression and anxiety more than others. Tere are several herbal medicines with positive e?ects in these patients. Te aim of this study is to evaluate the e?ects of mixture of &lt;/span&gt;&lt;span class="fontstyle3"&gt;Boswellia carterii&lt;/span&gt;&lt;span class="fontstyle2"&gt;, &lt;/span&gt;&lt;span class="fontstyle3"&gt;Zingiber ofcinale, &lt;/span&gt;&lt;span class="fontstyle2"&gt;and &lt;/span&gt;&lt;span class="fontstyle3"&gt;Achillea Millefolium &lt;/span&gt;&lt;span class="fontstyle2"&gt;on severity of symptoms, anxiety, and depression in IBS patients&lt;/span&gt;&lt;span class="fontstyle0"&gt;. Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Tis clinical trial study was done in sixty IBS patients (with mild?to?moderate symptoms) divided into two case and control groups. Patients were assessed at the beginning, 1 month, and 3 months after by IBS?severity scoring system (IBS?SSS) and Hospital Anxiety and Depression Scale. IBS?SSS is used for quality of life evaluation too. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Sixty IBS patients (with mild to moderate symptoms) with a mean age of 38.75 ± 11.74 participated that 55.4% of cases and 72.8% of controls were men. Te most prevalent type of IBS was the mixed type of IBS. Te mean score of abdominal pain severity and frequency, bloating score, and depression and anxiety score were decreased in patients administered herbal medication, but changes in these variables in controls were not statistically signifcant. Te changes in quality of life score between cases and controls were signifcant in men (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.01) although it was not signifcant in women. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #ed028c;"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;A mixture of &lt;/span&gt;&lt;span class="fontstyle3"&gt;B. Carterii&lt;/span&gt;&lt;span class="fontstyle2"&gt;, &lt;/span&gt;&lt;span class="fontstyle3"&gt;Z. ofcinale, &lt;/span&gt;&lt;span class="fontstyle2"&gt;and &lt;/span&gt;&lt;span class="fontstyle3"&gt;A. millefolium &lt;/span&gt;&lt;span class="fontstyle2"&gt;is e?ective in eliminating IBS symptoms&lt;br /&gt;and its related depression and anxiety and using herbal medicine in IBS treatment is suggested.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10726</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10726/5566</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus</title><FirstPage>10720</FirstPage><LastPage>10720</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Recent studies hypothesize that dyslipidemia can predict glycated hemoglobin (HbA1c) and could be important contributing factor to the pathogenesis of type 2 diabetes mellitus (DM2). Terefore, we aimed to evaluate the in?uence of lipidparameters on long?term glycemic control in DM2. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;A total of 275 sedentary DM2 (mean [±standarddeviation] age 60.6 [±10.0] years) who volunteered toparticipate in this cross?sectional study were enrolled. Anthropometric (bodyweight, body hight, and waist circumference), biochemical parameters (fasting glucose, HbA1c, lipid parameters, creatinine), aswell as blood pressure were obtained. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Total cholesterol (odds ratio [OR] =1.30, 95% confdence interval [CI] [1.02–1.66],&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.032), triglycerides (OR = 1.34, 95% CI (1.07–1.67), &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.010), and low density lipoprotein cholesterol (OR = 1.42, 95%CI [1.10–1.83], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.006) were the independent predictors of higher HBA1c, and as they increased by 1 mmol/L each, probabilitiesof higher HBA1c increased by 30%, 34%, and 42%, respectively. Low level of high?density lipoprotein cholesterol (HDL?c) was foundto be the independent predictor of higher HBA1c (OR = 0.44, 95% CI [0.20–0.67], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.039), and increase in HDL?c by 1 mmol/L,reduced the probability of higher HBA1c by 56%. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Unfavorable lipid profle can predict HbA1c level in DM2 patients.Early diagnosis of dyslipidemia, as well as its monitoring and maintaining good lipids control can be used as a preventive measurefor optimal long?term glycemic control.&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10720</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10720/5567</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">The relationship between fruit and vegetable intake with gastroesophageal reflux disease in Iranian adults</title><FirstPage>10719</FirstPage><LastPage>10719</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;table class="NormalTable"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="550"&gt;&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Findings from studies that investigated the relationship between fruit and vegetable intake with gastroesophageal re?ux disease (GERD) were inconsistent. We aimed to assess the relationship between fruit and vegetable consumption and GERD among a large group of  Iranian adults. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this cross?sectional study on  3979 adults, a validated food frequency questionnaire was used to assess usual dietary intakes including fruits and vegetables. Te presence of heartburn sometimes or more during the past 3 months were considered as having GERD. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Te prevalence of GERD among study population was 23.9%. After adjustment for potential confounding factors, those with the highest consumption of fruits had 25% lower risk for GERD, in comparison to those with the lowest intake (odds ratio [OR] = 0.75, 95% confdence interval [CI]: 0.59–0.97). Vegetable intake was not signifcantly related to the risk of GERD in crude or multivariable?adjusted models. However, participants with the highest intake of fruits and vegetables had 33% lower risk of GERD (OR = 0.67, 95% CI: 0.51–0.88), after  adjustment for confounders. Women with the highest fruit and vegetable intake had 36% lower risk for GERD (OR = 0.64, 95% CI: 0.45–0.91). Overweight/obese participants in the last tertile of fruit consumption had 42% lower risk for GERD, in comparison to the frst category (OR = 0.58, 95% CI: 0.42–0.83). Furthermore, participants with body mass index higher than 25 kg/m&lt;/span&gt;&lt;span class="fontstyle2" style="font-size: 5pt;"&gt;2 &lt;/span&gt;&lt;span class="fontstyle2"&gt;and higher intake of fruits and vegetables had 53% lower risk for GERD (OR = 0.47, 95% CI: 0.32?0.69). &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;We found inverse associations between fruit intake as well as fruit and vegetable intake and risk of GERD among Iranian adults.&lt;br /&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10719</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10719/5568</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Effect of Nepeta bracteata Benth. on allergic rhinitis symptoms: A randomized double-blind clinical trial</title><FirstPage>10721</FirstPage><LastPage>10721</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Context&lt;/span&gt;&lt;span class="fontstyle1"&gt;: Allergic rhinitis (AR) is one of the health problems in the world. It is necessary to develop new treatment procedure &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;for control of this  disease. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Aims&lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;: Te aim of this study was to assess the effect of &lt;/span&gt;&lt;span class="fontstyle3"&gt;Zofa &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;(&lt;/span&gt;&lt;span class="fontstyle3"&gt;Nepeta bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Benth) on AR patients. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Settings and Design: &lt;/span&gt;&lt;span class="fontstyle1"&gt;???. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;In this double-blind randomized clinical trial study, 71 patients (37 patients in treatment and 34 in placebo group) participated. In treatment group, &lt;/span&gt;&lt;span class="fontstyle3"&gt;N. bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;syrup (NBS) was used for 4 weeks as three times a day. Te efficacy of the drug regarding AR symptoms (rhinorrhea, sneezing, nasal obstruction, itchy nose, and ocular symptoms) were evaluated through a visual analog scale (VAS) by 0–10 before administration and at the end of the whole treatment period.&lt;br /&gt;&lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Statistical Analysis Used: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te collected information was entered in the SPSS software (version 18) and was analyzed using the Fisher’s exact test, Chi-square test, independent sample &lt;/span&gt;&lt;span class="fontstyle3"&gt;t&lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;-test, and paired sample test. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te improvement of AR symptoms in the group receiving NBS was significantly higher compared to control group (4.73 ± 1.84 vs. 0.38 ± 2.06; &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;&amp;lt; 0.0001). Furthermore, the mean of total VAS before and after the treatment (in case group) was 7.10 ± 1.92 and 2.37 ± 1.76, respectively (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;&amp;lt; 0.001). &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te results of this study indicate that &lt;/span&gt;&lt;span class="fontstyle3"&gt;N. bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;has significant effects on improving the symptoms of AR. Hence, it can be a good alternative to AR symptoms relief. &lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10721</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10721/5569</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Epidemiology of Q fever in Iran: A systematic review and meta?analysis for estimating serological and molecular prevalence</title><FirstPage>10722</FirstPage><LastPage>10722</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Q fever is endemic in Iran, thus, we conducted a systematic review and meta?analysis on epidemiology of &lt;/span&gt;&lt;span class="fontstyle3"&gt;Coxiella&lt;br /&gt;&lt;/span&gt;&lt;table class="NormalTable"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="550"&gt;&lt;span class="fontstyle3"&gt;burnetii &lt;/span&gt;&lt;span class="fontstyle2"&gt;among humans and animals in Iran. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;A systematic search was performed to identify all articles&lt;br /&gt;reporting &lt;/span&gt;&lt;span class="fontstyle3"&gt;C. burnetii &lt;/span&gt;&lt;span class="fontstyle2"&gt;prevalence in Iranian humans or animals, published from January 2000 to January 2015. Data from articles were extracted, and a pooled estimate of prevalence with corresponding 95% confdence interval (CI) was calculated using random e?ect method. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this review, 27 papers were identifed. Te pooled seroprevalence of Q fever in animals was 27% (CI 95%: 23%–32%). Te prevalence was 33% (CI 95%: 22%–45%) in goats, 27% (CI 95%: 21%–32%) in sheep, and 17% (CI 95%: 5%–28%) in cattle. Te bacterial DNA was detected in 5% (95% CI: 3%–9%) of milk samples, and it was higher in cattle (10%; 95% CI: 6%–16%) than sheep (2%; 95% CI: 0–7%) and goats (4%; 95% CI:  0–12%). &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusions: &lt;/span&gt;&lt;span class="fontstyle3"&gt;C. burnetii &lt;/span&gt;&lt;span class="fontstyle2"&gt;DNA or its antibody has been frequently detected among ruminants. Since these animals can transmit the infection to humans, Q fever could be a potential health problem in Iran.&lt;br /&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10722</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10722/5573</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis</title><FirstPage>10717</FirstPage><LastPage>10717</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;table class="NormalTable"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="550"&gt;&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Hepatitis C virus (HCV) is a major cause of liver disease and a potential cause of substantial morbidity and mortality. Tis study aims to provide a comprehensive evidence on HCV Infection in Iranian hemodialysis (HD) patients we conducted a systematic review. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this systematic review and meta-analysis, through a  comprehensive search of literature until January of 2016, we estimated the pooled prevalence of hepatitis C infection in Iranian HD patients. Using Medical Subject Headings terms, Emtree, and related equal Persian key words for Iranian databases and also international databases of PubMed and NLM Gateway (for MEDLINE), and SCOPUS. Interest outcome of HCV infection prevalence was confirmed based on positive hepatitis B surface antigen of blood samples. Random effect meta-analysis was used to estimate pooled prevalence of HCV infection in Iranian HD patients, date and language, HD patients, in adult HD patients, Institute of Scientific Information, Iran-doc, irrespective of age, living in Iran.  Searches run through main domestic databanks of Iran-Medex, renal transplantation, Scientific Information Database, the relevant literature-searched concentrating on HCV infection. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Trough searching steps, 305 publications were found from them following the excluding duplicates and overlapping studies 54 studies relevant to HCV prevalence in Iranian HD zcxw patients, with number of 23921 participants, remained in our  analyses. Te overall results of test of heterogeneity demonstrate sever&lt;br /&gt;heterogeneity between reported prevalence (&lt;/span&gt;&lt;span class="fontstyle3"&gt;I&lt;/span&gt;&lt;span class="fontstyle2" style="font-size: 5pt;"&gt;2 &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 96.62%, Chi-square = 1566, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001). Due to sever heterogeneity results of random effect meta-analysis showed that the estimated pooled prevalence was 11%  (95% confidence interval [CI] =10%–13%). Te pooled prevalence base on polymerase-chain reaction, recombinant immunoblot assay, and enzyme-Linked Immunosorbant Antibody method were 11% (95% CI = 6%–15%), 9% (95% CI = 5–13) and 12% (95% CI = 10–14), respectively. In line with previous studies, the present finding shows the significant variation in the rate of HCV in dialysis units among the regions in Iran. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusions: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Present paper is the comprehensive updated systematic review on HCV prevalence in the Iranian HD patients. Our findings provide the reliable evidence for promotion of policies and interventional programs. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10717</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10717/5571</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">An atypical presentation of pulmonary sequestration</title><FirstPage>10718</FirstPage><LastPage>10718</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Pulmonary sequestration (PS) is a rare congenital malformation of the lower respiratory tract and is commonly complicated by recurrent infections and presents with respiratory failure.&lt;/span&gt;&lt;span class="fontstyle0" style="color: #ec008c; font-size: 5pt;"&gt;[1] &lt;/span&gt;&lt;span class="fontstyle0"&gt;We report an atypical clinical presentation of postprandial abdominal pain and cramps in a patient with intralobar PS.&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10718</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10718/5572</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Can cool dialysate alleviate restless leg syndrome in hemodialysis patients?</title><FirstPage>10723</FirstPage><LastPage>10723</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">-</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10723</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10723/5570</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Accelerated rigor mortis: A case letter</title><FirstPage>10724</FirstPage><LastPage>10724</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">-</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10724</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10724/5574</pdf_url></Article></Articles>
